Chemical Component Summary

Name[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE
SynonymsLISINOPRIL
Identifiers(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
FormulaC21 H31 N3 O5
Molecular Weight405.49
TypeNON-POLYMER
Isomeric SMILESNCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O
InChIInChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1
InChIKeyRLAWWYSOJDYHDC-BZSNNMDCSA-N
CompositionPolymer Sequences: CLT|LYS|PRO
Non-Polymer Components: n/a
BIRD classENZYME INHIBITOR
Represented AsSINGLE MOLECULE
Compound Detailsn/a
Descriptionn/a

Chemical Details

Formal Charge0
Atom Count60
Chiral Atom Count3
Bond Count61
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00722 
NameLisinopril
Groups
  • approved
  • investigational
DescriptionLisinopril is an angiotensin converting enzyme inhibitor (ACEI) used to treat hypertension, heart failure, and myocardial infarction.[L8384,L8387,L8390] Lisinopril and [captopril] are the only ACEIs that are not prodrugs.[A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.[A184781,A184808,A184817] ACEIs are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers.[A184844] Lisinopril was granted FDA approval on 29 December 1987.[L8384]
Synonyms
  • Lisinoprilum
  • Lisinopril
  • [N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline
  • (S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline
  • Lisinopril dihydrate
Brand Names
  • Teva-lisinopril (type Z)
  • Lisinopril and Hydrochlorothiazide
  • Dom-lisinopril
  • Apo-lisinopril Tablet 5 mg
  • Lisinopril with Hydrochlorothiazide
IndicationLisinopril is indicated for the treatment of acute myocardial infarction, hypertension in patients ≥6 years, and as an adjunct therapy for heart failure.[L8384,L8387] A combination product with hydrochlorothiazide is indicated for the treatment of hypertension.[L8390]
Categories
  • ACE Inhibitors and Calcium Channel Blockers
  • ACE Inhibitors and Diuretics
  • Agents Acting on the Renin-Angiotensin System
  • Agents causing angioedema
  • Agents causing hyperkalemia
ATC-Code
  • C09BA03
  • C10BX07
  • C09AA03
  • C09BB03
CAS number76547-98-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Angiotensin-converting enzymeMGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFA...unknowninhibitor
ReninMDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERG...unknowninhibitor
Solute carrier family 15 member 1MGMSKSHSFFGYPLSIFFIVVNEFCERFSYYGMRAILILYFTNFISWDDN...unknownsubstrate,inhibitor
Solute carrier family 15 member 2MNPFQKNESKETLFSPVSIEEVPPRPPSPPKKPSPTICGSNYPLSIAFIV...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem11865407
PubChem5362119
PubChem139146300
ChEBICHEBI:43755
ChEMBLCHEMBL1237
PharosCHEMBL1237